College of Medicine, University of Florida, Gainesville, Florida, USA.
College of Nursing, University of Florida, Gainesville, Florida, USA.
Pediatr Diabetes. 2022 Dec;23(8):1687-1694. doi: 10.1111/pedi.13414. Epub 2022 Oct 9.
This study sought to examine the reliability and validity of a novel pediatric type 1 diabetes knowledge assessment (KAT-1) designed for children, adolescents, young adults and their parents/guardians. The instrument was designed to be integrated into the clinic workflow to obtain objective data electronically.
KAT-1 was developed by a multidisciplinary team and includes 11 independent topical subscales. Forty children/caregivers participated in a pilot study; their feedback was used to improve item clarity and readability. Subsequently, a validation study was performed in 200 participants (100 children/adolescents/young adults with type 1 diabetes ages 11-21 years and 100 parents/guardians of children with type 1 diabetes ages 1-15 years) to examine correlations between the KAT-1 scores and Revised Diabetes Knowledge Test (DKT2) scores and HbA1c. An item analysis was conducted to determine internal consistency and reliability; topical subscales were evaluated using Cronbach's alpha.
Total KAT-1 scores were positively correlated with DKT2 scores r = 0.674, p < 0.001, and negatively correlated with HbA1c, r = -0.3, p < 0.001. All KAT-1 subscales were positively and significantly correlated with one another and with total KAT-1 score. Internal consistency of total KAT-1 score was strong (Cronbach's α = 0.938, mean score 84.6, SD = 16.1) and 9 of 11 independent topical subscales demonstrated strong internal consistency. Completion time for subscales was <5 min.
KAT-1 is a valid instrument to assess type 1 diabetes knowledge. The instrument's short topical subscales can be used to objectively assess specific knowledge and individualize diabetes education. KAT-1 has been integrated into our electronic health record (EPIC) and is available online at no cost.
本研究旨在检验一种新的专为儿童、青少年、年轻成人及其父母/监护人设计的 1 型糖尿病知识评估工具(KAT-1)的信度和效度。该工具旨在整合到临床工作流程中,以电子方式获取客观数据。
KAT-1 由一个多学科团队开发,包括 11 个独立的主题子量表。40 名儿童/照顾者参加了试点研究;他们的反馈用于提高项目的清晰度和可读性。随后,在 200 名参与者(11-21 岁的 100 名 1 型糖尿病儿童/青少年/年轻成人和 100 名 1-15 岁的 1 型糖尿病儿童的父母/监护人)中进行了验证研究,以检验 KAT-1 评分与修订后的糖尿病知识测试(DKT2)评分和糖化血红蛋白(HbA1c)之间的相关性。进行了项目分析以确定内部一致性和可靠性;使用 Cronbach's alpha 评估主题子量表。
KAT-1 总分与 DKT2 评分呈正相关,r=0.674,p<0.001,与 HbA1c 呈负相关,r=-0.3,p<0.001。所有 KAT-1 子量表均与总分和彼此呈正相关且显著相关。KAT-1 总分的内部一致性很强(Cronbach's α=0.938,平均分数为 84.6,SD=16.1),11 个独立主题子量表中有 9 个显示出很强的内部一致性。子量表的完成时间<5 分钟。
KAT-1 是一种评估 1 型糖尿病知识的有效工具。该工具的简短主题子量表可用于客观评估特定知识并实现糖尿病教育个体化。KAT-1 已整合到我们的电子健康记录(EPIC)中,可免费在线获取。